Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus
This study has been completed.
Sponsor:
Merz Pharmaceuticals GmbH
Information provided by (Responsible Party):
Merz Pharmaceuticals GmbH
ClinicalTrials.gov Identifier:
NCT00955799
First received: August 6, 2009
Last updated: November 27, 2012
Last verified: November 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | June 2011 |
| Primary Completion Date: | May 2011 (Final data collection date for primary outcome measure) |
| Certification or Request for Extension to Delay Results Received: | November 27, 2012 |